Heart failure patients without echocardiography are more commonly diagnosed in hospital care and are associated with higher mortality compared to primary care

References

• Yasin ZM, Anderson PD, Lingman M, et al. Receiving care according to national heart failure guidelines is associated with lower total costs - an observational study in region Halland, Sweden. Eur Heart J Qual Care Clin Outcomes. 2021;7(3):280–286. doi: 10.1093/ehjqcco/qcaa020.
   PubMed Web of Science ®Google Scholar
• Jonsson Å, Edner M, Alehagen U, et al. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12(1):25–31. doi: 10.1093/eurjhf/hfp175.
   PubMed Web of Science ®Google Scholar
• Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85–151. doi: 10.1161/CIRCULATIONAHA.105.171600.
   PubMed Web of Science ®Google Scholar
• Agvall B, Paulsson T, Foldevi M, et al. Resource use and cost implications of implementing a heart failure program for patients with systolic heart failure in Swedish primary health care. Int J Cardiol. 2014;176(3):731–738. doi: 10.1016/j.ijcard.2014.07.105.
   PubMed Web of Science ®Google Scholar
• Zarrinkoub R, Wettermark B, Wändell P, et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013;15(9):995–1002. doi: 10.1093/eurjhf/hft064.
   PubMed Web of Science ®Google Scholar
• McDonagh T, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368.
   PubMed Web of Science ®Google Scholar
• Fonseca C, Morais H, Mota T, EPICA Investigators, et al. The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail. 2004;6(6):795–800. doi: 10.1016/j.ejheart.2004.08.002.
   PubMed Web of Science ®Google Scholar
• Verdú-Rotellar JM, Frigola-Capell E, Alvarez-Pérez R, et al. Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study. Eur J Gen Pract. 2017;23(1):107–113. doi: 10.1080/13814788.2017.1305104.
   PubMed Web of Science ®Google Scholar
• Muñoz MA, Mundet-Tuduri X, Real J, et al. Heart failure labelled patients with missing ejection fraction in primary care: prognosis and determinants. BMC Fam Pract. 2017;18(1):38. doi: 10.1186/s12875-017-0612-6.
   PubMedGoogle Scholar
• Davidge J, Ashfaq A, Ødegaard KM, et al. Clinical characteristics and mortality of patients with heart failure in Southern Sweden from 2013 to 2019: a population-based cohort study. BMJ Open. 2022;12(12):e064997. doi: 10.1136/bmjopen-2022-064997.
   PubMed Web of Science ®Google Scholar
• Stoupakis G, Klapholz M. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. Heart Dis. 2003;5(3):215–223. doi: 10.1097/01.HDX.0000074517.30102.64.
   PubMedGoogle Scholar
• Ewald B, Ewald D, Thakkinstian A, et al. Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction. Intern Med J. 2008;38(2):101–113. doi: 10.1111/j.1445-5994.2007.01454.x.
   PubMed Web of Science ®Google Scholar
• Costello-Boerrigter LC, Boerrigter G, Redfield MM, et al. Aminoterminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol. 2006;47(2):345–353. doi: 10.1016/j.jacc.2005.09.025.
   PubMed Web of Science ®Google Scholar
• Jernberg T, Stridsberg M, Lindahl B. Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction. Am J Cardiol. 2002;89(1):64–66. doi: 10.1016/s0002-9149(01)02166-x.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40(5):976–982. doi: 10.1016/s0735-1097(02)02059-4.
   PubMed Web of Science ®Google Scholar
• Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP investigation of dyspnea in the emergency department (PRIDE) study. J Am Coll Cardiol. 2006;47(1):91–97. doi: 10.1016/j.jacc.2005.08.051.
   PubMed Web of Science ®Google Scholar
• Januzzi JL, Chen-Tournoux AA, Christenson RH, et al. N-terminal pro-B-type natriuretic peptide in the emergency department: the ICON-RELOADED study. J Am Coll Cardiol. 2018;71(11):1191–1200. doi: 10.1016/j.jacc.2018.01.021.
   PubMed Web of Science ®Google Scholar
• Dahlström U, Håkansson J, Swedberg K, et al. Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden. Eur J Heart Fail. 2009;11(1):92–98. doi: 10.1093/eurjhf/hfn006.
   PubMed Web of Science ®Google Scholar
• Ashfaq A, Lönn S, Nilsson H, et al. Data resource profile: regional healthcare information platform in Halland, Sweden. Int J Epidemiol. 2020;49(3):738–739f. doi: 10.1093/ije/dyz262.
   PubMed Web of Science ®Google Scholar
• Mueller C, McDonald K, de Boer RA, Heart Failure Association of the European Society of Cardiology, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715–731. doi: 10.1002/ejhf.1494.
   PubMed Web of Science ®Google Scholar
• Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med. 2014;52:815–824.
   PubMed Web of Science ®Google Scholar
• Verdu-Rotellar JM, Vaillant-Roussel H, Abellana R, et al. Precipitating factors of heart failure decompensation, short-term morbidity and mortality in patients attended in primary care. Scand J Prim Health Care. 2020;38(4):473–480. doi: 10.1080/02813432.2020.1844387.
   PubMed Web of Science ®Google Scholar
• Agvall B, Alehagen U, Dahlström U. The benefits of using a heart failure management programme in Swedish primary healthcare. Eur J Heart Fail. 2013;15(2):228–236. doi: 10.1093/eurjhf/hfs159.
   PubMed Web of Science ®Google Scholar
• Giezeman M, Theander K, Zakrisson AB, et al. Exploration of the feasibility to combine patients with chronic obstructive pulmonary disease and chronic heart failure in self-management groups with focus on exercise self-efficacy. Scand J Prim Health Care. 2022;40(2):208–216. doi: 10.1080/02813432.2022.2073961.
   PubMed Web of Science ®Google Scholar